Prevalence and Impact of Cardiovascular Comorbidities on Disease Outcomes in a Middle Eastern Chronic Lymphocytic

Salem H Alshemmari1,2, Ahmed Alsarraf3, Abdulaziz Dashti4

  • 1Department of Medicine, Kuwait University, Kuwait City, Kuwait, salem61@gmail.com.

Insights

Comorbidities like vascular disease and diabetes mellitus significantly impact survival for chronic lymphocytic leukemia (CLL) patients. Integrated management is crucial, especially in high-risk populations.

Area of Science:

  • Hematology
  • Oncology
  • Epidemiology

Background:

  • Chronic lymphocytic leukemia (CLL) survival is influenced by comorbidities.
  • Kuwait has a high prevalence of cardiometabolic diseases, necessitating research into their impact on CLL patients.

Purpose of the Study:

  • To assess the prevalence of comorbidities in Kuwaiti CLL patients.
  • To determine the prognostic significance of comorbidities, especially diabetes mellitus and vascular disease, on survival outcomes in CLL.

Main Methods:

  • Retrospective cohort study of 316 CLL patients (2008-2021) at Kuwait Cancer Control Centre.
  • Data collected on demographics, clinical details, and comorbidities from medical records.
  • Overall survival (OS) analyzed using Kaplan-Meier curves and Cox proportional hazards models.

Main Results:

  • Most common comorbidities: hypertension (44%), diabetes mellitus (42%), dyslipidemia (10%).
  • Vascular disease strongly associated with inferior OS (adjusted HR 2.96; p=0.004).
  • Diabetes mellitus also linked to increased mortality (HR 1.74; p=0.034); unmutated IGHV status correlated with worse survival (p<0.001).

Conclusions:

  • Comorbidities, particularly vascular disease and diabetes mellitus, significantly impact CLL patient survival.
  • Integrated management strategies addressing both CLL and comorbidities are vital.
  • Findings are especially relevant for populations with high cardiometabolic risk.
Abstract

Related Concept Videos

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...